Oxford Nanopore Technologies: Nicholas Keher, Timothy Cowper
Oxford Nanopore Technologies CFO Nicholas Keher has been appointed as a director for three companies: Oxford Nanopore Diagnostics, Metrichor, and the Genome Foundry. Timothy Cowper, who recently stepped down from ONT's board of directors, will also no longer serve as a director to the same three companies. Keher became CFO of ONT in January. He previously served as CFO of Clinigen Group and Benevolent AI.
Standard BioTools: Alex Kim, Jeffrey Black, Sean Mackay
Standard BioTools has announced that CFO Jeffrey Black will resign, effective Aug. 31, to accept an opportunity at another public company. Cofounder and Chief Operating Officer Alex Kim will serve as interim CFO beginning Sept. 1. The firm has initiated a search for a permanent successor. Chief Business Officer Sean Mackay will add product management, marketing, and investor relations to his responsibilities.
Myriad Genetics: Jennifer Fox
Myriad Genetics appointed Jennifer Fox as chief legal officer, effective Sept. 3. Fox previously served as executive VP of external affairs at Emergent BioSolutions. Prior to that, she worked with Brinks, Gilson & Lione, Novozymes North America, and GlaxoSmithKline.
For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.